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Sciatic nerveDear Editor: we read with interest the article in this journal by
Michel et al. [1]. The authors aimed to devise a clinical assessment
score for diagnosis of piriformis muscle syndrome (PMS) [1,2]. They
used a range of tests to produce a diagnostic score for PMS;
however, to conﬁrm the diagnosis, no diagnostic test such as local
piriformis muscle (PM) injection was used. The diagnosis of PMS is
difﬁcult on clinical grounds alone and often difﬁcult to treat.
However, local injection of an anesthetic and corticosteroids into
the PM to relieve pain may also reconﬁrm the diagnosis in terms of
therapeutic success [3–6]. The marked and almost immediate
relief of pain produced by inﬁltration of the PM is considered a
diagnostic aid for PMS [7]. Therefore, PMS should be diagnosed on
the basis of clinical symptoms, speciﬁc physical examinations, and
positive response to local injection.
Older injection techniques were done blindly [8,9], whereas
currently, nerve stimulation, electromyography (EMG), ﬂuorosco-
py, CT, MRI and ultrasonography are used to guide the PM injection
[10–13]. Michel et al. identiﬁed the PM by EMG. The conﬁrmatory
techniques the authors used may not be considered highly
accurate for positioning, because nearby muscles with similar
actions as the PM can produce an artifact [14]. Positioning should
be validated with imaging techniques in which the muscle and the
injected material are identiﬁed with certainty [14].
In some studies, injections of botulinum toxin (BTX) seem safe
and effective for PMS [15] and have given more relief from pain
than lidocaine with steroids or placebo [16], but another study
found no signiﬁcant differences between BTX and 0.5% bupivacaine
[17]. Furthermore, in one study, BTX led to atrophy and fatty
degeneration of the PM that could be quantiﬁed by MRI
[18]. Therefore, considering the high cost and potential risks ofDOIs of original articles: http://dx.doi.org/10.1016/j.rehab.2013.04.003, http://
dx.doi.org/10.1016/j.rehab.2015.02.001
http://dx.doi.org/10.1016/j.rehab.2015.01.005
1877-0657/ 2015 Elsevier Masson SAS. All rights reserved.BTX, its use as ﬁrst-line treatment does not seem appropriate.
Instead, injecting the PM with a local anesthetic with or without
corticosteroids should be considered earlier for therapeutic and
diagnostic purposes [19].
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